IPGP
IPG Photonics Corporation
IPGP's outlook is improving, though it still trails on the overall score.
NVDA
NVIDIA Corporation
NVDA has the edge over IPGP overall, supported by stronger valuation and stronger fundamentals.
IPGP Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Strong |
IPGP's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
IPGP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 21x | $19.24 | -73% |
| Forward | 35x | $70.86 | — |
| Fair | 47x | $43.25 | -39% |
| Current | 76x | $70.86 | — |
| Expensive | 111x | $103 | +46% |
Historical ranges are pointers, not guarantees.
IPGP's PE is in its expensive range at 76x. If earnings grow as analysts expect, today's price would be 35x next year's earnings, in its fair range.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over IPGP in the historical PE scenario, which offers more potential upside but is not a forecast.
IPGP Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
IPGP has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
IPGP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +118% |
| Q3 2026 | $0.93 | +33% |
| Q2 2026 | $0.64 | +$5.45 |
| Q1 2026 | $0.68 | +$5.20 |
| Q4 2025 | $0.73 | +$4.82 |
| Q3 2025 | $0.70 | +$4.16 |
| Q2 2025 | -$4.81 | -259% |
| Q1 2025 | -$4.52 | -216% |
| Q4 2024 | -$4.09 | -188% |
IPGP's earnings per share have fallen from their peak: $0.93 over the past year, against $5.21 in early 2022.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over IPGP on earnings, with more consistent year-over-year improvement.
IPGP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $287.5M | +15% |
| Q2 2026 | $278.6M | +11% |
| Q1 2026 | $265.5M | +17% |
| Q4 2025 | $274.5M | +17% |
| Q3 2025 | $250.8M | +7.6% |
| Q2 2025 | $250.7M | -2.7% |
| Q1 2025 | $227.8M | -9.6% |
| Q4 2024 | $234.3M | -22% |
IPGP's revenue is recovering but still below its 2021 peak: $288M last quarter, up 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +4.1 points |
| Q2 2026 | 1.6% | +1.6 points |
| Q1 2026 | -2.9% | -3.7 points |
| Q4 2025 | 1.2% | -4.7 points |
| Q3 2025 | 3.1% | +112 points |
| Q2 2025 | 0% | -4.6 points |
| Q1 2025 | 0.8% | -6.8 points |
| Q4 2024 | 6% | -3.7 points |
IPGP's operating margin was 7.2% last quarter, up 4.1 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over IPGP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over IPGP on profitability, with a higher operating margin.
IPGP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.8M | +98% |
| Q2 2026 | $17.1M | +$34.7M |
| Q1 2026 | -$21.8M | -$10.4M |
| Q4 2025 | $10.9M | -78% |
| Q3 2025 | $14.6M | -66% |
| Q2 2025 | -$17.6M | -160% |
| Q1 2025 | -$11.4M | -143% |
| Q4 2024 | $50.6M | -37% |
IPGP still generates free cash flow, though less than at its 2019 peak: $35M over the past year.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over IPGP on cash flow, with more consistent year-over-year improvement.
IPGP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -72.9K shares |
| 1 year | +0.7% | +284K shares |
| 3 years | -9.6% | -4.5M shares |
| 5 years | -20% | -11M shares |
| Available history | -20% | -11M shares |
IPGP has 43M diluted shares, up 0.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.6M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2024 | $57.3M |
| Q3 2024 | $74.5M |
| Q2 2024 | $122.4M |
| Q1 2024 | $89.6M |
| Q4 2023 | $64M |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over IPGP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
IPGP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -8.1x | Net Cash |
| Q2 2026 | -5.3x | Net Cash |
| Q1 2026 | -6.8x | Net Cash |
| Q4 2025 | -5.1x | Net Cash |
| Q3 2025 | -4.1x | Net Cash |
| Q2 2024 | -4.0x | Net Cash |
| Q1 2024 | -2.0x | Net Cash |
| Q4 2023 | -1.7x | Net Cash |
IPGP has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
IPGP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.4 | Neutral |
| Stochastic | 17.8 | Oversold |
IPGP's weekly RSI is 39 (neutral) and its Stochastic is 18 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
IPGP PE vs Technology Sector
| Metric | IPGP | Sector median | Relative |
|---|---|---|---|
| PE | 76x | 28x | 173% above |
| PE % | 76 | 35 | 41 pts above |
IPGP is trading at 76x earnings, a 173% premium to the Technology sector's median of 28x.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over IPGP on valuation relative to its sector.
IPGP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $73.9 | 4.1% below |
| 20 week MA | $82.3 | 14% below |
| 50 week MA | $97.2 | 27% below |
| 100 week MA | $84.6 | 16% below |
| 200 week MA | $90.9 | 22% below |
IPGP is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over IPGP on trend strength, trading above more of its moving averages.
IPGP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $143.9 | $221.0 | +54% |
| 2021 | $221.0 | $168.9 | -24% |
| 2022 | $168.9 | $92.9 | -45% |
| 2023 | $92.9 | $108.5 | +17% |
| 2024 | $108.5 | $73.4 | -32% |
| 2025 | $73.4 | $75.2 | +2.4% |
| 2026 YTD | $75.2 | $70.9 | -5.7% |
IPGP has the edge over NVDA on returns for 2026, with the stronger performance.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.